The third-party medicine manufacturing company is an example of an extremely strategic business partnership whereby a marketing company outsources its production processes to a certified manufacturer. This model is also widely known in the industry as pharma contract manufacturing, or working with a contract manufacturing organization (CMO) — the terms get used interchangeably, so don’t be thrown if you see “third party” and “contract manufacturing” side by side in a vendor’s pitch. This way, brand owners only need to engage with the marketing aspect of their business, leaving all other operations of the production lifecycle to specialists in the field. Furthermore, this particular model greatly reduces the costs of capital investment, thus becoming perfect for use by any pharmaceutical startup in India.
The pharmaceutical sector calls for a high level of efficiency, strict quality control, and great potential for quick scalability. Therefore, partnering with one of the leading third-party drug manufacturing companies guarantees convenient and immediate access to a great industrial infrastructure without spending any considerable funds. Besides, following strict regulatory policies guarantees that all pharmaceutical batches meet all the necessary global safety standards. Overall, this model makes it much easier for modern pharmaceutical entrepreneurs in India to increase their profitability.
Ultimately, every successful brand relies on a trusted third-party medicine manufacturing company to scale operations rapidly.
What Is Third Party Medicine Manufacturing?
Third-party medicine manufacturing is an arrangement where a brand owner supplies the formula and packaging design, and a certified manufacturer handles sourcing, production, testing, and delivery — then hands back finished, ready-to-sell medicine carrying the brand owner’s name. That’s the plain third-party pharma manufacturing meaning: you’re the marketing company, they’re the factory, and you never own or run a plant yourself. In the industry this same setup gets called pharma contract manufacturing, or working with a contract manufacturing organization (CMO) — don’t be thrown if a vendor uses the terms interchangeably, because they are.
Think of it like renting a fully staffed kitchen instead of building your own restaurant. You bring the recipe; they bring the equipment, the licenses, and the trained hands.
One distinction worth knowing before you go further: third-party manufacturing isn’t the same as loan licensing. In loan licensing, you borrow someone else’s drug license to manufacture under. In third-party manufacturing, the manufacturer’s own license and facility cover everything — you’re not borrowing anything, you’re outsourcing the whole job.
The Third-Party Medicine Manufacturing Process, Step by Step
The third-party medicine manufacturing process runs in eight steps — formulation sharing, documentation, sample batch approval, bulk production, quality testing, packaging, climate-controlled storage, and delivery — and takes 30 to 45 days start to finish when the sample batch clears on the first try. If you’ve searched how third-party medicines are manufactured or how third-party medicines are made, this is that process broken down honestly, not as a marketing summary.
1. Formulation and Requirement Sharing
You hand over the formula, dosage form, and packaging spec. This is also where mismatches surface early — if your formulation needs a niche excipient or an odd pack size, flag it now, before the manufacturer sources standard materials assuming you didn’t.
2. Documentation and Regulatory Compliance
Drug license, GST certificate, PAN card, and trademark documentation all go to the manufacturer before production starts. A manufacturer willing to skip this step isn’t doing you a favor — they’re handing you a compliance risk you’ll be the one holding later.
3. Sample Batch and Approval
A small batch gets made first, matching your formulation exactly. You approve it — or don’t — before bulk production begins. Every stage after this one gets more expensive to fix, which makes this the cheapest place in the entire medicine manufacturing process flow to catch a problem.
4. Bulk Production in a WHO-GMP Certified Plant
Once you sign off, full production runs inside a WHO-GMP certified facility using certified raw materials. Nothing dramatic happens operationally here — it’s just the manufacturer executing at scale what the sample already proved works.
5. Quality Control and Stability Testing
Every batch is lab-tested, including stability studies that check how heat and humidity affect the drug over time. This step is what actually separates a serious third-party pharma manufacturer from a corner-cutter — ask to see the testing documentation, don’t just take their word for it.
6. Packaging and Labeling
Products are packed under your brand name, logo, and design. Most manufacturers offer full packaging customization, so this stays genuinely your call.
7. Climate-Controlled Storage and Dispatch
For injectables, syrups, and anything temperature-sensitive, stability has to hold through storage and transit, not just testing. Refrigerated logistics matters here as much as the manufacturing itself did.
8. Delivery
The finished, packed product reaches your storage or distribution point — typically 30 to 45 days from step one. Delays usually trace back to documentation gaps in step 2, not production. If you’re comparing third-party manufacturing lead time against building in-house, that comparison isn’t close: in-house adds months of plant setup before a single batch even starts.
What Documents Are Required for Third-Party Medicine Manufacturing?
Third-party medicine manufacturing requires six things from the brand owner before production starts: a Drug License, GST Certificate, PAN Card, trademark documentation, a signed manufacturing agreement, and a non-disclosure agreement (NDA) covering the formulation. Skipping any of these before production begins is exactly the compliance risk flagged earlier in this guide’s Risks section — a manufacturer willing to start without them is handing you a problem, not a shortcut.
What you submit to the manufacturer:
- Drug License — proof you’re authorized to market pharmaceutical products under your brand
- GST Certificate — your business’s GST registration
- PAN Card — company or proprietor PAN
- Trademark documentation — for your brand name and logo, so packaging can legally carry it
- Signed manufacturing agreement — spells out exclusivity, minimum order commitments, liability if a batch fails quality testing, and who owns the formulation IP
- Non-disclosure agreement (NDA) — signed before the manufacturer sees your formulation, so you retain the intellectual property rights throughout the relationship
What the manufacturer sends back, once production is underway:
- Certificate of Analysis (COA) for each batch
- Batch records and testing reports documenting GMP-compliant production
- Full regulatory documentation supporting compliance and, where relevant, export eligibility
Start the Drug License paperwork first if you don’t have one yet — it’s the slowest piece of this list by a wide margin, and every other document can move in parallel while it processes.
What Are the Key Benefits of Third-Party Medicine Manufacturing?
The biggest benefits of third-party medicine manufacturing are lower capital risk, faster market entry, and compliance that’s already built into the plant you’re renting capacity from. You skip building your own factory — which can save ₹50 lakh or more in setup costs alone — while your team stays focused on marketing and sales instead of running production.
| Benefit Category | Operational Advantage | Financial Impact |
|---|---|---|
| Capital Efficiency | Eliminates the need to build, manage, and maintain heavy manufacturing infrastructure. | Can save ₹50 lakh or more in initial plant setup costs. |
| Operational Focus | Internal teams can focus more on brand marketing, sales, and business development. | Supports faster market entry and earlier revenue generation. |
| Regulatory Compliance | Manufacturing is carried out at facilities that meet applicable quality and regulatory standards. | Reduces compliance-related risks and supports consistent product quality. |
| Scalability | Batch volumes can be adjusted according to changes in market demand. | Helps optimize inventory costs and reduce the risk of stock shortages. |
These are the same points that come up whenever brand owners weigh third-party manufacturing vs. in-house manufacturing: less capital tied up, a shorter runway to your first sale, and a compliance foundation you didn’t have to build from zero.
What Products Can Be Manufactured Under Third-Party Medicine Manufacturing?
Third-party medicine manufacturing covers nearly every pharmaceutical dosage form — injectables, tablets, capsules, syrups, drops, and ointments — produced and packed under the brand owner’s own name rather than the manufacturer’s. Intelico Pharmaceuticals’ third-party manufacturing portfolio spans 11 categories and 350+ formulations, giving a real picture of what a WHO-GMP certified third-party manufacturer actually covers in practice.
Injectables and sterile formats
- Critical care injectables — antibiotics, anti-infectives, antifungals, cardiovascular agents, and analgesics
- Prefilled syringes — ready-to-administer sterile injectables for hospital use
- Anti-cancer / oncology injectable molecules
Oral solid and liquid formats
- Tablets and capsules — general and specialty oral solids
- Soft gelatin capsules (softgels)
- Cough syrups, oral suspensions, and dry syrups
Topical and specialty formats
- Eye and ear drops — sterile ophthalmic and otic formulations
- Ointments and creams — topical, external-use semisolids
- Nutraceuticals
- Unique molecules — novel or differentiated formulations, including combination therapies
- Products for export only — formulations built to meet international regulatory requirements
Packaging spans glass vials and ampoules for injectables, blister packs for tablets and capsules, bottles for oral liquids and drops, and fully custom branded designs under the client’s own trade name.
Not every third-party manufacturer covers this full range — a plant built for oral solids won’t necessarily handle sterile injectables, which is also part of why cost varies so much by product (see the Cost section above). Intelico Pharmaceuticals is one of the few manufacturers covering this entire range under one roof, so a brand owner isn’t forced to split their portfolio across multiple partners as new products get added.
Third-Party Manufacturing Cost: What It Actually Takes to Get Started
Third-party medicine manufacturing costs ₹2,00,000 to ₹5,00,000 for most first-time brands in India, covering your first production batch, licensing, and packaging — not a plant, machinery, or staff. If your search was simply how much does third-party pharma manufacturing cost, that’s your starting-point range before the variables below move the number up or down.
What Drives the Third-Party Manufacturing Cost in India
Three things move your number: how many products you launch, which dosage form you pick, and your batch size. One or two products in a simple oral form lands you at the low end, around ₹2 lakh. Go wider, or go injectable, and the number climbs — injectables simply cost more per unit than tablets or syrups. This is the real reason third-party pharma manufacturing cost in India quotes swing so widely between vendors: two brands asking “what’s the cost” can land 3x apart just because one’s launching tablets and the other’s launching injectables.
Per-Unit Manufacturing Cost, With Real Numbers
A basic antibiotic injectable runs ₹18–20 per vial in bulk. Push into lyophilized or oncology formulations and that jumps past ₹65 a vial — complexity shows up directly in price. Order bigger, and the per-vial cost drops, which is why most brands start lean and scale batch size as demand proves itself rather than betting big on day one. For tablets specifically, a single batch run — usually tied to a Minimum Order Quantity (MOQ) of 30,000–50,000 units — typically runs ₹60,000–₹95,000 before licensing and GST. That’s the number to use if you’re trying to calculate third-party manufacturing cost per product rather than per company.
What’s Included in the Initial Investment
Your starting capital covers three things, full stop: your first batch, your Drug License and GST registration, and your packaging and brand design. Start the Drug License paperwork first. It’s the slowest piece by a wide margin, and there’s no reason to let it hold up everything else.
Third-Party Manufacturing Cost vs. Building Your Own Plant
A compliant in-house facility runs into multiple crores once you count cleanrooms, machinery, and validation. A third-party partner cuts that by up to 60%, because you’re stepping into infrastructure that’s already built, licensed, and running — not paying to build anything from scratch. Third-party manufacturing cost vs. in-house manufacturing cost isn’t a close comparison for a first-time brand. It’s lakhs against crores.
How to Choose the Right Third-Party Medicine Manufacturing Company?
Choosing the right third-party medicine manufacturing company comes down to five checks: valid certifications, real infrastructure, a product range that matches your portfolio, verifiable market reputation, and transparent, itemized pricing. Skip any one of these and you’re trusting the rest on faith.
Check Certifications
Verified manufacturing certifications confirm the production unit actually meets national and international quality standards — not just claims to. Partnering with an established, WHO-GMP certified third-party manufacturer gives an emerging brand instant credibility with distributors and regulators alike.
Evaluate Infrastructure
Look past the sales pitch to the plant itself: modern machinery is what actually delivers precision and batch-to-batch consistency, and a facility built to handle large-scale production won’t buckle the moment your order volumes grow.
Review Product Range
A manufacturer with a broad catalog — tablets, syrups, capsules, injectables — lets you expand into new therapeutic areas without switching partners every time your product line grows.
Analyze Market Reputation
A manufacturer’s track record with past clients tells you more than their pitch deck does. Consistent, on-time deliveries protect your brand’s reputation in a market where a single stockout can cost you a distributor relationship.
Evaluate Pricing Transparency
Ask any shortlisted vendor directly how they calculate third-party manufacturing cost for your specific product mix. A transparent manufacturer breaks the quote down by batch size and dosage form on request — one flat number with no breakdown is itself a red flag.
Top 10 Third-Party Medicine Manufacturing Companies in India
India’s top third-party medicine manufacturing companies are WHO-GMP certified producers that make finished pharmaceutical products on a brand owner’s behalf, evaluated here on plant certification, location, and product-range fit rather than brand recall alone. Whether you’re comparing the best third-party medicine manufacturers in India generally or specifically hunting a WHO-GMP certified third-party pharma manufacturer for injectables, the specialties below should narrow your shortlist fast.
- Intelico Pharmaceuticals — WHO-GMP certified, producing tablets, capsules, injectables, and liquid syrups for PCD franchise and pharma marketing partners across India.
- Akums Drugs & Pharmaceuticals Ltd. — India’s largest pharma CDMO, running 15+ WHO-GMP certified plants covering tablets, capsules, injectables, and APIs.
- Theon Pharmaceuticals Ltd. — Himachal Pradesh-based, focused on β-lactam, cephalosporin, and dry powder injectable formulations.
- Cipla Ltd. — global generics company offering third-party manufacturing from USFDA and EU-GMP certified facilities in Goa and Maharashtra, across respiratory, anti-infective, and specialty categories.
- Intas Pharmaceuticals Ltd. — Ahmedabad-headquartered, 10+ facilities worldwide, with contract manufacturing built into its core business model.
- Blue Cross Laboratories Ltd. — Mumbai-based, WHO-GMP certified plants in Nasik and Goa, running third-party production alongside its own established brands.
- 9M India Ltd. — Chhattisgarh-based, Schedule M and WHO-GMP compliant, producing liquid orals, tablets, capsules, small-volume injectables, and ORS.
- Lifevision Healthcare — ISO-WHO-GMP certified, plants in Chandigarh and Baddi, covering tablets, capsules, syrups, and softgels.
- Associated Biotech — WHO-GMP and EU-compliant, based in Baddi, specializing in cephalosporin, beta-lactam, nutraceutical, and ayurvedic manufacturing.
- Swisschem Healthcare — Panchkula, Haryana-based, ISO 9001 and WHO-GMP certified, producing tablets, capsules, syrups, injectables, and pellets.
How to Pick Among These Third-Party Medicine Manufacturers
Match three things before you compare price: plant certification (WHO-GMP is the baseline; EU-GMP or USFDA if you’re exporting), location (Himachal Pradesh and the Chandigarh–Panchkula belt dominate India’s third-party manufacturing hub thanks to tax incentives), and product-range overlap with your own portfolio.
Note: certifications and specialties reflect current public company information as of August 2026 — worth a final spot-check before publishing, since manufacturer credentials and facility details do change.
Third-Party Manufacturing Risks: Red Flags to Watch For Before You Sign
The biggest risk in third-party manufacturing isn’t quality — it’s picking a manufacturer who cuts corners on documentation. Six red flags catch most bad partnerships before they cost you: no current WHO-GMP certificate, a vague or missing manufacturing agreement, skipping the sample batch, unclear or shifting pricing, no stability testing data on record, and turnaround-time promises that sound too fast to be real.
No WHO-GMP Certificate, or One That’s Expired
If a manufacturer can’t produce a current WHO-GMP certificate on request, walk away. This isn’t paperwork theater — it’s the baseline proof their facility meets safety standards, and stalling on this question tells you something on its own.
Vague or Missing Manufacturing Agreement
A real agreement spells out exclusivity, minimum order commitments, liability if a batch fails quality testing, and who owns the formulation IP. A manufacturer willing to start on a verbal understanding or a one-page form isn’t being efficient — that’s exposure, and it’s yours to carry, not theirs.
No Sample Batch Before Bulk Production
Skipping the sample batch to save time is the single most common mistake first-time brands make. It feels faster. It isn’t — a formulation problem caught after a full bulk run costs far more than the few days a sample batch takes.
Unclear or Shifting Pricing
Quotes that change after you’ve committed, or pricing that’s never broken down by batch size and dosage form, usually mean margin is being padded somewhere you can’t see. Get pricing in writing, tied to specific batch sizes, before signing anything.
No Stability Testing Data
Ask to see actual stability testing documentation, not just a claim that it happens. A manufacturer who can’t produce this for past batches probably isn’t running it consistently — and that’s a direct risk to shelf life and patient safety.
Overpromising on Turnaround Time
Genuine production cycles run 30–45 days once documentation is finalized. A manufacturer quoting significantly faster than that for a first-time client is either cutting a step or setting up a delay they’ll blame on something else later.
Why Choose Intelico Pharmaceuticals?
Intelico Pharmaceuticals is a WHO-GMP and ISO 9001:2015 certified third-party manufacturer based in Baddi, Himachal Pradesh, bringing over 32 years of combined industry expertise to contract manufacturing services.
- Advanced WHO-GMP-certified facilities equipped with modern automated machinery.
- A skilled quality-control team running checks at every stage of manufacturing.
- A wide product portfolio: tablets, capsules, injectables, and liquid syrups.
- Competitive pricing built to protect client profit margins.
- Reliable scheduling that keeps growing businesses supplied without gaps.
Working with Intelico means product quality, regulatory compliance, and market growth handled by one partner — which is why a growing number of startups run their entire production through us.
The Bottom Line
Succeeding in India’s pharmaceutical market comes down to picking the right manufacturing partner and moving early. A third-party medicine manufacturing partnership lets you skip the heavy infrastructure spend and start selling in weeks, not years — and understanding the process, real costs, and red flags above is what makes that partnership work instead of becoming a liability. At Intelico Pharmaceuticals, that’s the whole job: quality control, regulatory compliance, and dependable delivery, so your brand can focus on growth.
Frequently Asked Questions
How do manufacturers protect proprietary formulas?
Through a signed non-disclosure agreement (NDA) — the manufacturer commits to it before seeing your formulation, and you retain the IP rights throughout.
What is the minimum order quantity (MOQ) for third-party manufacturing?
Most manufacturers set the initial batch size at 50,000 units, though this varies by dosage form — tablet MOQs can run as low as 30,000 units.
Are stability studies performed before release?
Yes. Every batch goes through stability testing that checks how temperature and humidity affect the drug over time, before it’s cleared for market release.
Where are raw materials sourced from?
From ISO certified, validated global chemical suppliers — procurement teams verify each source before materials enter production.
Can startups customize product packaging?
Yes — packaging design, brand logo, and color scheme are entirely the brand owner’s call, not something you’re stuck accepting as-is.
What regulatory documents does the client need to provide?
Drug license, GST certificate, PAN card, and trademark documentation, all submitted before production begins.
How is temperature maintained during transport?
Through climate-controlled warehouses and refrigerated transport, built specifically for pharmaceuticals that can’t tolerate temperature swings.
What’s the average turnaround time for third-party manufacturing?
30 to 45 days from signed documentation to delivery, assuming the sample batch is approved on the first try.
Do manufacturers help with licenses?
Experienced manufacturers typically support license approval and provide the documentation needed to get there.
How is third-party manufacturing pricing structured?
Pricing depends on ingredient cost, batch size, packaging material, and total production volume — which is exactly why two brands can get very different quotes for the same dosage form.